Wolfgang Eiermann Selected Research

Wolfgang Eiermann Research Topics

Disease

58	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2002
25	Neoplasms (Cancer) 01/2020 - 05/2004
3	Fatigue 02/2020 - 04/2011
3	Disease Progression 01/2018 - 05/2004
3	Inflammatory Breast Neoplasms 05/2014 - 01/2010
3	Pathologic Complete Response 01/2014 - 12/2005
2	Cardiotoxicity 01/2022 - 10/2011
2	Nausea 02/2020 - 08/2005
2	Anemia 02/2020 - 01/2018
2	Triple Negative Breast Neoplasms 02/2020 - 07/2014
2	Ductal Carcinoma 01/2020 - 02/2014
2	Wounds and Injuries (Trauma) 01/2020 - 02/2014
2	Carcinoma (Carcinomatosis) 10/2017 - 04/2013
2	Venous Thrombosis (Deep-Vein Thrombosis) 02/2016 - 05/2014
2	Heart Failure 10/2011 - 01/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Neutropenia 02/2020
1	Alopecia (Baldness) 02/2020
1	Stroke (Strokes) 02/2016
1	Spasm (Spasms) 02/2016
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016
1	Thrombosis (Thrombus) 05/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	Leukemia 10/2011
1	Colorectal Neoplasms (Colorectal Cancer) 07/2011
1	Headache (Headaches) 07/2011
1	Pain (Aches) 07/2011
1	Arthralgia (Joint Pain) 07/2011
1	Hypertension (High Blood Pressure) 04/2011
1	Lobular Carcinoma 07/2010

Drug/Important Bio-Agent (IBA)

19	Trastuzumab (Herceptin)FDA Link 01/2022 - 12/2003
11	Hormones (Hormone)IBA 02/2020 - 11/2005
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2015 - 12/2005
9	AnthracyclinesIBA 01/2022 - 01/2005
8	taxaneIBA 11/2019 - 01/2005
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 12/2003
7	Paclitaxel (Taxol)FDA LinkGeneric 10/2017 - 12/2003
7	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 12/2005
7	Fluorouracil (Carac)FDA LinkGeneric 10/2015 - 12/2005
6	ErbB Receptors (EGF Receptor)IBA 02/2020 - 01/2005
6	Docetaxel (Taxotere)FDA Link 08/2013 - 05/2004
5	human ERBB2 proteinIBA 11/2019 - 05/2012
5	Tamoxifen FDA LinkGeneric 02/2016 - 11/2002
4	Capecitabine (Xeloda)FDA Link 02/2020 - 08/2013
4	Ado-Trastuzumab EmtansineIBA 11/2019 - 01/2017
4	pertuzumabIBA 11/2019 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2013
4	Anastrozole (Arimidex)FDA LinkGeneric 02/2016 - 11/2002
3	Vinorelbine (Navelbine)FDA LinkGeneric 02/2020 - 08/2013
3	Tumor Biomarkers (Tumor Markers)IBA 11/2019 - 01/2019
3	Phenobarbital (Luminal)FDA Link 10/2017 - 05/2012
3	Epirubicin (Ellence)FDA LinkGeneric 10/2015 - 11/2007
3	Pharmaceutical PreparationsIBA 05/2014 - 01/2005
3	Biomarkers (Surrogate Marker)IBA 12/2012 - 10/2008
3	Estrogen ReceptorsIBA 12/2012 - 12/2005
3	Carboplatin (JM8)FDA LinkGeneric 10/2011 - 05/2004
3	Goserelin (Zoladex)FDA Link 07/2011 - 08/2006
2	talazoparibIBA 02/2020 - 01/2018
2	eribulin FDA Link 02/2020 - 01/2018
2	Poly Adenosine Diphosphate RiboseIBA 02/2020 - 01/2018
2	Gemcitabine FDA Link 02/2020 - 01/2018
2	Aromatase InhibitorsIBA 02/2016 - 11/2002
2	ParaffinIBA 01/2014 - 12/2012
2	Estrogens (Estrogen)FDA Link 12/2012 - 01/2005
2	Letrozole (Femara)FDA LinkGeneric 10/2008 - 11/2002
1	Codon (Codons)IBA 01/2022
1	Biological ProductsIBA 01/2021
1	cabazitaxel FDA Link 10/2017
1	130-nm albumin-bound paclitaxelIBA 10/2015
1	IceIBA 10/2015
1	RNA (Ribonucleic Acid)IBA 01/2014
1	Formaldehyde (Formol)FDA Link 01/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 09/2013
1	Oncostatin MIBA 04/2013
1	LigandsIBA 04/2013
1	EpiregulinIBA 04/2013
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 04/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2012
1	Fulvestrant (Faslodex)FDA Link 06/2012
1	Alkylating AgentsIBA 10/2011
1	Taxoids (Taxanes)IBA 10/2011
1	Zoledronic Acid (Zometa)FDA Link 07/2011
1	motesanib diphosphateIBA 04/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011
1	Bevacizumab (Avastin)FDA Link 04/2011
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 03/2011
1	EnzymesIBA 03/2011
1	Diphosphonates (Bisphosphonates)IBA 04/2010

Therapy/Procedure

22	Therapeutics 01/2022 - 11/2002
17	Drug Therapy (Chemotherapy) 01/2022 - 05/2004
12	Neoadjuvant Therapy 10/2017 - 04/2006
6	Segmental Mastectomy (Lumpectomy) 01/2021 - 07/2010
6	Radiotherapy 01/2021 - 07/2010
5	Adjuvant Chemotherapy 01/2019 - 10/2008
1	Mastectomy (Mammectomy) 01/2020
1	Adjuvant Radiotherapy 01/2020
1	Contraindications 02/2016